10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Perceptive Advisors Joseph Edelman | 8,086,159 | $92,263,074 | 1.95% | |
2. | Baker Bros. Advisors Julian Baker And Felix Baker | 6,443,398 | $73,519,171 | 0.76% | |
3. | Vestal Point Capital Ryan Wilder | 3,750,000 | $42,787,500 | +37% | 3.24% |
4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,501,962 | $28,547,386 | -24% | 0.24% |
5. | OrbiMed Advisors Samuel Isaly | 2,006,381 | $22,892,807 | 0.41% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 6,352,929 | $66,896,342 | 0.01% | |
2. | 2,969,039 | $31,263,981 | 1.74% | |
3. | 2,136,339 | $22,495,650 | 1.05% | |
4. | 1,548,909 | $16,310,012 | 0% | |
5. | 1,484,911 | $15,636,113 | 0.24% |